Immatics at Antibody Engineering & Therapeutics Asia (Feb 24-26) in Kyoto, Japan

| News, USA

Latest Science, Technology and Partners to Accelerate Antibody & Protein Therapies, ADCS, Bispecifics and Immuno-Oncology

Meet Immatics at Antibody Engineering & Therapeutics Asia in Kyoto to discuss and fast-track next-generation therapeutics for cancer patients!


Monday, Feb 24, 10.25am – 11am 

Pre-Conference Workshop

Effective Targeting of Tumor-specific pMHC Targets with Bispecific T cell-engaging Receptor (TCER™) Molecules

Speaker: Dominik Maurer, VP Immunology  


We are looking forward to seeing you there!
Further information on Antibody Engineering & Therapeutics Asia here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.